Prithviraj Bose
@bose_prithviraj
Professor, Leukemia at MD Anderson; myeloproliferative neoplasm expert. Tweets reflect my own views; not necessarily my institution's.
ID:1323100096293146629
02-11-2020 03:10:42
331 Tweets
1,1K Followers
595 Following
Follow People
Check out the final results of our IST of sotatercept for anemia of MF published in Haematologica: 55 patients, RR around 30% both alone and with rux MD Anderson Cancer Center Bristol Myers Squibb Hagop Kantarjian,MD #sergeverstovsek #MPNSM
doi.org/10.3324/haemat…
Unwinding in Osaka’s Dotonbori area after a long but engaging and enjoyable day of sessions at MPN Asia Abdulraheem Yacoub #johnmascarenhas missed you Ruben A. Mesa, MD J.J. Kiladjian
Ready for a great MPN meeting in Osaka !
Thrilled to discuss with colleagues from Asia and share experience in the management of patients with #MPNsm Abdulraheem Yacoub Harry Gill, MD FRCP FRCPath Ruben A. Mesa, MD Chih-Cheng Chen Prithviraj Bose
Our review is published online Blood Advances : patients w PV <60y of age, cytoRx esp w IFN is not so bad! So why isn’t it standard of care yet? Congratulations Reem Chamseddine, WeillCornellQatar students, Weill Cornell Medicine coauthors ashpublications.org/bloodadvances/…
On this #RareDiseaseDay , Prithviraj Bose, of MD Anderson Cancer Center, speaks on the importance of raising awareness through advocacy groups and highlights the prevalence of rare diseases such as #myelofibrosis and #polycythemiavera .
📺 Watch here: buff.ly/49xZelg
Reflecting on highlights from our 2023 MPN-MDS US focus meeting! Co-chair Prithviraj Bose provided insightful takeaways that we look forward to delivering again this year.
Get ready for more in 2024 - dive into the agenda and secure your spot today!
🔗bit.ly/3tPDtxS
WATCH: Experts discuss several recent data updates in polycythemia vera and myelofibrosis in the context of the treatment landscape and its impact on clinical practice. Gaby Hobbs Andrew Kuykendall MD Prithviraj Bose Pankit Vachhani Ashwin Kishtagari, MD #oncology onclive.com/view/majic-pv-…
⚠️ #ESHMPN2024 DON'T MISS THE FINAL DEADLINE TO SUBMIT YOUR ABSTRACT ➡️ bit.ly/3PALAGS
10th Translational Research Conference
MYELOPROLIFERATIVE NEOPLASMS
🗓️ April 26-28, 2024 in Mandelieu 🇫🇷
Chairs: J.J. Kiladjian, Ross Levine, Jyoti Nangalia
#ESHCONFERENCES #MPNsm
What is the current landscape in the treatment of #Myelofibrosis , and what does the future hold?
Prithviraj Bose of MD Anderson Cancer Center shares some updates and insights from #ASH2023 .
Watch the interview here:
👉ow.ly/weoA50QyPmn
#MPNsm #HemOnc @ASH_Hematology
Happy to share our review on #MPNsm A true clinical & pathological approach written w/ my friends Prithviraj Bose Pankit Vachhani
See if you can guess the Dx from image before looking at the paper 😉
Free full text:
authors.elsevier.com/c/1iZqS7fNb0Dz…
Primary or secondary myelofibrosis, does it make a difference?
See our experience Hôpital Saint-Louis AP-HP AP-HP Université Paris Cité AmericanJournalofHematology #MPNsm #CentreIntégréDesNMP
👉 doi.org/10.1002/ajh.27…
#ESHMPN2024 DON'T MISS THE DEADLINE TO SUBMIT YOUR ABSTRACT: Feb 12th!
Proceed now➡️bit.ly/3PALAGS
10th Translational Research Conference MYELOPROLIFERATIVE NEOPLASMS
April 26-28 2024 in Mandelieu🇫🇷
Chairs J.J. Kiladjian Ross Levine Jyoti Nangalia
#ESHCONFERENCES #MPNsm
Really enjoyed filming this series of videos on #MPNSM at #ASH23 with Gaby Hobbs, Prithviraj Bose, Pankit Vachhani, and Ashwin Kishtagari, MD. Glad to see them online! onclive.com/peer-exchange/…
#ASH23 | Prithviraj Bose (@MDAndersonNews) shares the initial results from Summit, a trial investigating bezuclastinib in adult patients with non-advanced systemic #Mastocytosis .
Click here to watch:
👉ow.ly/IpCN50QpAH0
#MPNsm #CTSM #TrialUpdate #HemOnc @ASH_Hematology
Prithviraj Bose from the MD Anderson Cancer Center and Rami komrokji from Moffitt Cancer Center are co-chairing our 4th annual MPN-MDS US Focus meeting, and with a great agenda and amazing networking opportunities make sure to sign up today!
🔗 👉 bit.ly/3tPDtxS
#MPN #MDS #HemOnc